NPB-3

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNPB-3
Drug Alias Nametherapeutic antibody B3 (NeoPharm)NPB-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis, AtopicRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeopharm
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A